Logo image of SRAD

SPORTRADAR GROUP AG-A (SRAD) Stock Fundamental Analysis

NASDAQ:SRAD - Nasdaq - CH1134239669 - Common Stock - Currency: USD

25.2  +0.39 (+1.57%)

After market: 25.48 +0.28 (+1.11%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SRAD. SRAD was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. SRAD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SRAD is valued quite expensive, but it does show an excellent growth. These ratings would make SRAD suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SRAD was profitable.
SRAD had a positive operating cash flow in the past year.
SRAD had positive earnings in each of the past 5 years.
In the past 5 years SRAD always reported a positive cash flow from operatings.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With a Return On Assets value of 2.32%, SRAD perfoms like the industry average, outperforming 51.49% of the companies in the same industry.
SRAD has a better Return On Equity (6.05%) than 61.94% of its industry peers.
With a Return On Invested Capital value of 4.33%, SRAD perfoms like the industry average, outperforming 43.28% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SRAD is significantly below the industry average of 14.01%.
The last Return On Invested Capital (4.33%) for SRAD is above the 3 year average (3.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.32%
ROE 6.05%
ROIC 4.33%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

The Profit Margin of SRAD (5.12%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SRAD has remained more or less at the same level.
SRAD has a Operating Margin (10.79%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of SRAD has remained more or less at the same level.
With an excellent Gross Margin value of 73.07%, SRAD belongs to the best of the industry, outperforming 89.55% of the companies in the same industry.
In the last couple of years the Gross Margin of SRAD has declined.
Industry RankSector Rank
OM 10.79%
PM (TTM) 5.12%
GM 73.07%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRAD is destroying value.
SRAD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SRAD has been increased compared to 5 years ago.
Compared to 1 year ago, SRAD has an improved debt to assets ratio.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

SRAD has an Altman-Z score of 3.33. This indicates that SRAD is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.33, SRAD is doing good in the industry, outperforming 77.61% of the companies in the same industry.
SRAD has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.33, SRAD belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that SRAD is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.04, SRAD belongs to the best of the industry, outperforming 84.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.33
Altman-Z 3.33
ROIC/WACC0.76
WACC5.67%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

SRAD has a Current Ratio of 1.35. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
SRAD has a Current ratio of 1.35. This is in the better half of the industry: SRAD outperforms 68.66% of its industry peers.
SRAD has a Quick Ratio of 1.35. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.35, SRAD is doing good in the industry, outperforming 72.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.23% over the past year.
SRAD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.84% yearly.
The Revenue has grown by 23.08% in the past year. This is a very strong growth!
SRAD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.81% yearly.
EPS 1Y (TTM)69.23%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%4073.68%
Revenue 1Y (TTM)23.08%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%17.05%

3.2 Future

SRAD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.45% yearly.
SRAD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.06% yearly.
EPS Next Y166.75%
EPS Next 2Y97.75%
EPS Next 3Y81.32%
EPS Next 5Y66.45%
Revenue Next Year16.77%
Revenue Next 2Y15.99%
Revenue Next 3Y15.48%
Revenue Next 5Y13.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 100.80, which means the current valuation is very expensive for SRAD.
SRAD's Price/Earnings ratio is a bit more expensive when compared to the industry. SRAD is more expensive than 60.45% of the companies in the same industry.
SRAD is valuated expensively when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 50.91, which means the current valuation is very expensive for SRAD.
Based on the Price/Forward Earnings ratio, SRAD is valued a bit more expensive than the industry average as 62.69% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.19. SRAD is valued rather expensively when compared to this.
Industry RankSector Rank
PE 100.8
Fwd PE 50.91
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

SRAD's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRAD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 41.61
EV/EBITDA 14.85
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SRAD may justify a higher PE ratio.
A more expensive valuation may be justified as SRAD's earnings are expected to grow with 81.32% in the coming years.
PEG (NY)0.6
PEG (5Y)4.62
EPS Next 2Y97.75%
EPS Next 3Y81.32%

0

5. Dividend

5.1 Amount

No dividends for SRAD!.
Industry RankSector Rank
Dividend Yield N/A

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (6/18/2025, 8:00:00 PM)

After market: 25.48 +0.28 (+1.11%)

25.2

+0.39 (+1.57%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)N/A N/A
Inst Owners79.07%
Inst Owner Change2.14%
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap7.53B
Analysts83.81
Price Target27.42 (8.81%)
Short Float %3.01%
Short Ratio3.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.63%
Min EPS beat(2)-100%
Max EPS beat(2)141.26%
EPS beat(4)2
Avg EPS beat(4)54.91%
Min EPS beat(4)-100%
Max EPS beat(4)278.4%
EPS beat(8)3
Avg EPS beat(8)13.27%
EPS beat(12)5
Avg EPS beat(12)-16.74%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.98%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)2.39%
Revenue beat(4)3
Avg Revenue beat(4)2.56%
Min Revenue beat(4)-0.42%
Max Revenue beat(4)4.89%
Revenue beat(8)4
Avg Revenue beat(8)0.37%
Revenue beat(12)7
Avg Revenue beat(12)0.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.53%
PT rev (3m)27.78%
EPS NQ rev (1m)3.11%
EPS NQ rev (3m)-23.75%
EPS NY rev (1m)0%
EPS NY rev (3m)15.39%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)1.96%
Valuation
Industry RankSector Rank
PE 100.8
Fwd PE 50.91
P/S 5.68
P/FCF 41.61
P/OCF 16.87
P/B 6.72
P/tB N/A
EV/EBITDA 14.85
EPS(TTM)0.25
EY0.99%
EPS(NY)0.5
Fwd EY1.96%
FCF(TTM)0.61
FCFY2.4%
OCF(TTM)1.49
OCFY5.93%
SpS4.43
BVpS3.75
TBVpS-3.33
PEG (NY)0.6
PEG (5Y)4.62
Profitability
Industry RankSector Rank
ROA 2.32%
ROE 6.05%
ROCE 5.9%
ROIC 4.33%
ROICexc 5.22%
ROICexgc N/A
OM 10.79%
PM (TTM) 5.12%
GM 73.07%
FCFM 13.66%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
ROICexc(3y)4.06%
ROICexc(5y)5.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.52%
ROCE(5y)4.82%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y7.36%
ROICexc growth 5Y-3.96%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.33
Debt/EBITDA 0.1
Cap/Depr 77.98%
Cap/Sales 20.03%
Interest Coverage 1.57
Cash Conversion 92.36%
Profit Quality 266.99%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 3.33
F-Score7
WACC5.67%
ROIC/WACC0.76
Cap/Depr(3y)86.86%
Cap/Depr(5y)86.55%
Cap/Sales(3y)21.89%
Cap/Sales(5y)22.44%
Profit Quality(3y)195.32%
Profit Quality(5y)194.81%
High Growth Momentum
Growth
EPS 1Y (TTM)69.23%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%4073.68%
EPS Next Y166.75%
EPS Next 2Y97.75%
EPS Next 3Y81.32%
EPS Next 5Y66.45%
Revenue 1Y (TTM)23.08%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%17.05%
Revenue Next Year16.77%
Revenue Next 2Y15.99%
Revenue Next 3Y15.48%
Revenue Next 5Y13.06%
EBIT growth 1Y32.84%
EBIT growth 3Y36.08%
EBIT growth 5Y22.83%
EBIT Next Year117.47%
EBIT Next 3Y51.41%
EBIT Next 5Y36.59%
FCF growth 1Y877.26%
FCF growth 3Y347.38%
FCF growth 5Y21.32%
OCF growth 1Y111.14%
OCF growth 3Y38.73%
OCF growth 5Y19.31%